SCHEMBL3985258

SCHEMBL3985258

Clc1cc(On2nnc3cccnc32)ncn1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 4/20 0.34
MGLL Q99685 4/20 0.34
CDC7 O00311 1/20 0.32
DAPK3 O43293 1/20 0.32
MAP4K4 O95819 1/20 0.32
PIM1 P11309 1/20 0.32
PRKACA P17612 1/20 0.32
FLT3 P36888 1/20 0.32
CDK8 P49336 1/20 0.32
CLK2 P49760 1/20 0.32
GSK3B P49841 1/20 0.32
CDK7 P50613 1/20 0.32
CDK9 P50750 1/20 0.32
PRKX P51817 1/20 0.32
CDK5 Q00535 1/20 0.32
DYRK1A Q13627 1/20 0.32
PKN2 Q16513 1/20 0.32
MINK1 Q8N4C8 1/20 0.32
HIPK2 Q9H2X6 1/20 0.32
CLK4 Q9HAZ1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4369906 0.90 FAAH (0.34) FAAHMGLLTUBB4ATUBBTUBA3C
SCHEMBL4089288 0.81 KMT2A (0.45)
SCHEMBL29890284 0.73 FAAH (0.33) FAAHMGLLTUBB4ATUBBTUBA3C
SCHEMBL13624546 0.72 SYK (0.33) FAAHMGLLTUBB4ATUBBTUBA3C
SCHEMBL3978381 0.71 RAB9A (0.41) PDE4BPDE4D
SCHEMBL15862649 0.70 FAAH (0.39) FAAHMGLLPDE4BPDE4DTUBB4A
SCHEMBL3978450 0.70 FAAH (0.34) FAAHMGLLPDE4BPDE4DTUBB4A
SCHEMBL798141 0.70 FAAH (0.41) FAAHMGLLPDE4BPDE4DTUBB4A
SCHEMBL13624542 0.69 ALDH1A1 (0.33) FAAHMGLLPDE4BPDE4DTUBB4A
SCHEMBL30014935 0.69 SIRT6 (0.43) FAAHMGLLPDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090291971-A1 HETEROARYL ETHERS AND PROCESSES FOR THEIR PREPARATION WYETH (US) 2009-11-26 US disclosed
US-20090291971-A1 HETEROARYL ETHERS AND PROCESSES FOR THEIR PREPARATION WYETH (US) 2009-11-26 US disclosed
WO-2009058937-A2 HETEROARYL ETHERS AND PROCESSES FOR THEIR PREPARATION WYETH (US) 2009-05-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090291971-A1 HETEROARYL ETHERS AND PROCESSES FOR THEIR PREPARATION AHR, MALT1, ABL1 FAAH 1951/4885MGLL 3975/4885CDC7 2352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.